Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat
Ruzicka, J.A.; Ruenitz, P.C.
Drug Metabolism and Disposition the Biological Fate of Chemicals 20(5): 770-772
1992
ISSN/ISBN: 0090-9556 PMID: 1358584 Document Number: 393192
Document emailed within 1 workday
Related Documents
Chen, L.; Waxman, D.J.; Chen, D.; Kufe, D.W. 1996: Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene Cancer Research 56(6): 1331-1340Granvil, C.P.; Wang, T.; Batist, G.; Wainer, I.W. 1994: Influence of phenobarbital induction on the enantioselective N-dechloroethylation of ifosfamide enantiomers in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(1): 165-167
Colvin, M. 1982: The comparative pharmacology of cyclophosphamide and ifosfamide Seminars in Oncology 9(4 Suppl 1: 2-7
Gad-el-Mawla, N.; Ziegler, J.L.; Hamza, R.; Elserafi, M.; Khaled, H. 1984: Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder Cancer Treatment Reports 68(2): 419-421
Brock, N.; Stekar, J.; Pohl, J.; Niemeyer, U.; Scheffler, G. 1979: Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide Arzneimittel-Forschung 29(4): 659-661
Norpoth, K.; Addicks, H.W.; Witting, U.; Mŭller, G.; Raidt, H. 1975: Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) Arzneimittel-Forschung 25(9): 1331-1336
Miller, A.; Henderson, M.C.; Buhler, D.R. 1978: Cytochrome P-450-mediated covalent binding of hexachlorophene to rat tissue proteins Molecular Pharmacology 14(2): 323-326
Kim, C.H.; King, T.E. 1991: Effect of pyridoxal phosphate on the formation of cytochrome c1-c and cytochrome c-cytochrome oxidase complexes Biochemistry International 24(2): 255-262
Preskorn, S.H.; Alderman, J.; Greenblatt, D.J.; Horst, W.D. 1997: Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo Psychopharmacology Bulletin 33(4): 659-665
Dalvi, R.R.; Dalvi, P.S.; Lane, C. 2004: Cytochrome P450-mediated activation and toxicity of chlorpyrifos in male and female rats Veterinary and Human Toxicology 46(6): 297-299
Bennett, B.M.; McDonald, B.J.; St James, M.J. 1992: Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate Journal of Pharmacology and Experimental Therapeutics 261(2): 716-723
Rohde, K.; Blanck, J.; Ruckpaul, K. 1983: Kinetics of elementary steps in the cytochrome P-450 reaction sequence. VI. Model treatment of the NADPH-dependent first electron transfer reaction between cytochrome P-450 reductase and cytochrome P-450 LM2 in solution Biomedica Biochimica Acta 42(6): 651-662
Chen, L.; Yu, L.J.; Waxman, D.J. 1997: Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase gene Cancer Research 57(21): 4830-4837
Mohandas, J.; Duggin, G.G.; Horvath, J.S.; Tiller, D.J. 1981: Regional differences in peroxidatic activation of paracetamol (acetaminophen) mediated by cytochrome P450 and prostaglandin endoperoxide synthetase in rabbit kidney Research Communications in Chemical Pathology and Pharmacology 34(1): 69-80
Mattammal, M.B.; Zenser, T.V.; Palmier, M.O.; Davis, B.B. 1985: Renal reduced nicotinamide adenine dinucleotide phosphate:cytochrome c reductase-mediated metabolism of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide Cancer Research 45(1): 149-156
Ha, T.G.; Kim, N.D. 1998: 2-(allylthio)pyrazine inhibition of aflatoxin B1-induced hepatotoxicity in rats: inhibition of cytochrome P450 2B- and 3A2-mediated bioactivation Research Communications in Molecular Pathology and Pharmacology 102(1): 69-78
Gorsky, L.D.; Coon, M.J. 1986: Effects of conditions for reconstitution with cytochrome b5 on the formation of products in cytochrome P-450-catalyzed reactions Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(1): 89-96
Grishanova, A.Iu.; Mishin, V.M.; Liakhovich, V.V. 1985: Interaction between cytochrome P-448 and NADP-cytochrome P-450 reductase in reconstituted microsomal membranes Biokhimiia 50(3): 369-374
Yasui, N. 1996: The relationship between single-oral dose kinetics of alprazolam and cytochrome P4503A and cytochrome P4502C19 Nihon Shinkei Seishin Yakurigaku Zasshi 16(3): 109-112
Yamazaki, H.; Nakajima, M.; Nakamura, M.; Asahi, S.; Shimada, N.; Gillam, E.M.; Guengerich, F.P.; Shimada, T.; Yokoi, T. 1999: Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(9): 999-1004